Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06291818 · ClinicalTrials.gov registry record · NA
Self-Adhering Magnetic Device to Treat Corneal Exposure
A NA study of Paralytic Lagophthalmos and Corneal Exposure, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06291818 is a NA study of Paralytic Lagophthalmos and Corneal Exposure that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06291818, a NA study of Paralytic Lagophthalmos and Corneal Exposure, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.
Conditions Studied
Interventions
- DEVICE temporary magnetic system for tarsorrhaphy (MST)
Study Locations (1)
Illinois
- University of Illinois - Specialty Care Building - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-04-17 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06291818
The ClinicalTrials.gov registry entry for NCT06291818 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Paralytic Lagophthalmos appearing as the primary indexed condition, and to 1 intervention - of which temporary magnetic system for tarsorrhaphy (MST) is the first listed.
NCT06291818 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06291818 about?
NCT06291818 is a clinical study titled "Self-Adhering Magnetic Device to Treat Corneal Exposure". Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex co...
What is the current status of trial NCT06291818?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-04-17. Estimated completion is 2025-04-01.
What conditions does trial NCT06291818 study?
This clinical trial studies the following conditions: Paralytic Lagophthalmos, Corneal Exposure.
What interventions are being tested in trial NCT06291818?
The interventions under investigation include: temporary magnetic system for tarsorrhaphy (MST) (DEVICE).
Who is sponsoring clinical trial NCT06291818?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06291818 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.